Leadership
Faculty
Regis B. Kelly, PhD—Director
Prior to joining QB3 in 2004, Regis Kelly served as executive vice-chancellor at UCSF; he oversaw the UCSF research enterprise and was also responsible for construction of the new Mission Bay campus. He is currently chairman of the Bay Area Scientific Innovation Consortium and has served on the boards of the Malaysian Biotechnology Industry Advisory Board, the Scleroderma Foundation, and Bridge Pharmaceuticals. He is an advisor to the Thailand Bionanotechnology Institute, Ho Chi Minh City Biotechnology Department Corp., University of Oxford Systems Biology Program, and the San Francisco Mayor’s Biotechnology Advisory Group. He joined the UCSF Department of Biochemistry in 1971 and has served as director of the Cell Biology Graduate Program, director of the Hormone Research Institute, and chair of the Department of Biochemistry and Biophysics. He earned an undergraduate degree in physics from the University of Edinburgh and a PhD in biophysics from the California Institute of Technology.
David Haussler, PhD—Director, QB3-Santa Cruz
David Haussler holds a UC Presidential Chair in Computer Science, is director of the Center for Biomolecular Science & Engineering at UC Santa Cruz, and is a Howard Hughes Medical Institute (HHMI) Investigator. He earned his undergraduate degree in mathematics from Connecticut College, and his PhD in computer science from the University of Colorado at Boulder. David Haussler’s webpage
Susan Marqusee, MD, PhD—Director, QB3-Berkeley
Susan Marqusee is a professor of molecular and cell biology in UC Berkeley’s Division of Biochemistry and Molecular Biology. She received her AB in Physics and Chemistry from Cornell University, and her MD and PhD degrees from Stanford University. After a post-doctoral fellowship at MIT, she joined the UC Berkeley faculty. Susan Marqusee’s webpage
Andrej Sali, PhD—Director, QB3-UCSF
Andrej Sali is a professor in the Department of Bioengineering and Therapeutic Sciences at UCSF. He received his BSc in chemistry from the University of Ljubljana, Slovenia, and his PhD in molecular biophysics from the University of London, UK. Andrej Sali’s webpage
Marc A. Shuman, MD—Clinical Director
Marc Shuman is professor of medicine and urology and co-leader of the Prostate Cancer Program in the Comprehensive Cancer Center at UCSF. In addition to being an oncologist-hematologist, he spends 30 percent of his time as clinical director of the QB3 Clinical Associates Program and head of the QB3 Anti-Medical School. His research lab is focused on understanding the genetic and biochemical mechanisms of tumor progression in prostate and breast cancers. Previously at UCSF, Shuman was chief of the Hematology and Oncology Division, and held positions in the Comprehensive Cancer Center including Associate Director for Research and Education and Associate Director for Program Development. He has been a member of the Cancer Center Executive Committee since its inception. He served as director of the Molecular Medicine Program in the School of Medicine for several years. He obtained his MD from Thomas Jefferson Medical College and has practiced at UCSF since 1976.
Innolab
Douglas Crawford, PhD—Associate Director
Douglas Crawford’s goal is to help stimulate economic growth in California by promoting cross-discipline academic research and accelerating the transfer of the resulting innovations to the market. Crawford created and manages the first incubator within the University of California, the QB3 Garage@UCSF, which has now expanded to include the QB3 Garage@Berkeley, the QB3 Mission Bay Innovation Center, and the QB3 East Bay Innovation Center. Together these incubators are currently home to 42 companies. Crawford is also a founder and managing director of Mission Bay Capital, an $11.3M seed-stage venture fund that seeks to make pivotal early-stage investments in bioscience companies emerging from UC. He is a board member of Redwood Biosciences (observer), Delpor, and the BayBio Institute. Crawford received his PhD in biochemistry from UCSF.
Kenneth Harrison, PhD—Entrepreneurship Program Manager
Kenneth Harrison works to ensure the success of QB3 Garage/Innovation Network companies by lowering barriers to getting successful startups off the ground. He works directly with founders to generate and maintain successful, well-structured companies through the QB3 Startup in a Box program and promotes the development of the biotech industry in San Francisco through QB3’s BioSF program. While in graduate school, Ken evaluated licensing opportunities for early-stage discoveries with the Yale University Office of Cooperative Research and completed coursework at the Yale School of Management. He studied cellular lipid metabolism as an A.P. Giannini Foundation Postdoctoral Fellow at the J. David Gladstone Institutes and vascular biology as an American Heart Association Fellow at the Yale University School of Medicine. He earned his BSc in molecular biology from Texas Tech University where he was an HHMI Undergraduate Research Fellow and his PhD in pharmacology from Yale.
Neena Kadaba, PhD—Director, Industry Alliances
Neena Kadaba works to initiate new collaborations between industry and QB3 campus scientists and manages QB3’s multi-year, multimillion dollar alliance with Pfizer. She runs the Quadrant industry speakers seminar series to link scientists from industry to scientists in academia and startups, and manages QB3’s internship program. Previously, she co-founded Cypress Innovations and was an associate and Kauffman Fellow in the venture capital group at Itochu Technology. She earned her BS at the Massachusetts Institute of Technology and her PhD in chemistry at the California Institute of Technology.
Kaspar Mossman, PhD—Communications Director
Kaspar Mossman engages internal and external stakeholders in QB3’s mission to support research and commercialization in quantitative biosciences. He manages the QB3 website, newsletter, email and event marketing, multimedia, social media, and print publications. Previously, he was an AAAS mass media fellow at Scientific American and a staff writer at Proceedings of the National Academy of Sciences. He earned a PhD in biophysics from UC Berkeley.